Evidence map›Paper›PMID 42704493›Full record

ArticleJournal of molecular modeling2026

Comparative molecular dynamics of two cyclic peptide inhibitors bound to the Zika virus NS2B/NS3 protease.

Camilla Vitoria Silva Marinho, Maycon Vinicius Damasceno de Oliveira, Anderson H Lima

Abstract readComparative Study
In one paragraph

Article in Journal of molecular modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Camilla Vitoria Silva MarinhoLaboratório de Planejamento e Desenvolvimento de Fármacos, Instituto de Ciências Exatas e Naturais, Universidade Federal do Pará, Belém, Pará, 66075-110, Brazil.ORCID http://orcid.org/0000-0002-6162-3848
Maycon Vinicius Damasceno de OliveiraLaboratório de Planejamento e Desenvolvimento de Fármacos, Instituto de Ciências Exatas e Naturais, Universidade Federal do Pará, Belém, Pará, 66075-110, Brazil.ORCID http://orcid.org/0000-0003-2263-2124
Anderson H LimaLaboratório de Planejamento e Desenvolvimento de Fármacos, Instituto de Ciências Exatas e Naturais, Universidade Federal do Pará, Belém, Pará, 66075-110, Brazil. anderson@ufpa.br.ORCID http://orcid.org/0000-0002-8451-9912

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextThe Zika virus NS2B/NS3 protease is an important antiviral target, and macrocyclic peptide inhibitors represent promising scaffolds because they combine multibasic recognition motifs with conformational restriction. Here, we investigated two structurally related cyclic peptide inhibitors, referred to as CP1 and CP2, which share a conserved macrocyclic framework but differ in the chemical nature of their linker substituents. Molecular dynamics simulations showed that both peptides display broad intramolecular distance distributions in aqueous solution, indicating that key crystallographic contacts are not intrinsically maintained in the unbound state. Upon binding to the protease, CP2 adopted a more defined conformational ensemble and preserved a short intramolecular contact compatible with its crystallographic arrangement, whereas CP1 lost its crystallographic d2 contact and sampled a broader bound-state distribution. CP2 also showed a more focused interaction network involving residues from the catalytic and substrate-recognition regions and more favorable binding free-energy estimates.

methodsMolecular dynamics simulations were performed for each cyclic peptide in aqueous solution and bound to the Zika virus NS2B/NS3 protease using Amber 20. The protein was described with the ff14SB force field, the cyclic peptides with GAFF2, and the systems were solvated with the TIP3P water model. Three independent 500 ns simulations were performed for each system. Trajectories were analyzed using structural clustering, intramolecular distance distributions, residue-level interaction analysis, and MM/PBSA and MM/GBSA binding free-energy calculations.

Indexed as

Molecular Dynamics SimulationPeptides, CyclicProtease InhibitorsSerine EndopeptidasesViral Nonstructural ProteinsZika VirusDEAD-box RNA HelicasesNucleoside-TriphosphataseProtein BindingProtein ConformationViral ProteasesDEAD-box RNA HelicasesNS2B protein, flavivirusNS3 protein, Zika virusNucleoside-TriphosphatasePeptides, CyclicProtease InhibitorsSerine EndopeptidasesViral Nonstructural ProteinsViral ProteasesBinding free energyConformational preorganizationMacrocyclic peptidesZIKV protease

Identifiers

PMID42704493
PMCPMC13550072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.